Search

Your search keyword '"Gardini, Giorgio"' showing total 18 results
Start Over Author "Gardini, Giorgio" Search Limiters Peer Reviewed
18 results on '"Gardini, Giorgio"'

7. Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases

Author

Carlinfante, Gabriele, Baccarini, Paola, Berretti, Debora, Cassetti, Tiziana, Cavina, Maurizio, Conigliaro, Rita, De Pellegrin, Alessandro, Di Tommaso, Luca, Fabbri, Carlo, Fornelli, Adele, Frasoldati, Andrea, Gardini, Giorgio, Losi, Luisa, Maccio, Livia, Manta, Raffaele, Pagano, Nico, Sassatelli, Romano, Serra, Silvia, and Camellini, Lorenzo

Published
2014
Full Text
View/download PDF

13. Pedunculated Angiomyofibroblastoma of the Vulva: Case Report and Review of the Literature

Author

Giannella, Luca, Costantini, Matteo, Mfuta, Kabala, Cavazza, Alberto, Cerami, Lillo Bruno, Gardini, Giorgio, and Boselli, Fausto

Subjects
Article Subject
Abstract

Angiomyofibroblastoma (AMFB) is a rare benign mesenchymal tumour that occurs almost exclusively in the vulvovaginal region of women but can also occur occasionally in the inguinoscrotal region of men. It is a well-circumscribed lesion that clinically is often thought to represent a Bartholin's gland cyst and usually does not form a pedunculated mass. To our knowledge, only five cases of vulvar AMFB with pedunculated mass have been reported in the English literature and all cases involving the labia majora and middle-aged women. We report the first case of pedunculated AMFB of the vulva occurring in a young woman of 21 years old and involving the left labia minora. After excluding the most common diseases, pedunculated AMFB should be part of differential diagnosis in the workup of any pedunculated vulvar mass even in young women with a lesion involving the labia minora. We reviewed the literature and summarized all reported cases.

Published
2011
Full Text
View/download PDF

14. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Author

Brandes, Alba A., Franceschi, Enrico, Ermani, Mario, Tosoni, Alicia, Albani, Fiorenzo, Depenni, Roberta, Faedi, Marina, Pisanello, Anna, Crisi, Girolamo, Urbini, Benedetta, Dazzi, Claudio, Cavanna, Luigi, Mucciarini, Claudia, Pasini, Giuseppe, Bartolini, Stefania, Marucci, Gianluca, Morandi, Luca, Zunarelli, Elena, Cerasoli, Serenella, and Gardini, Giorgio

Subjects
GLIOBLASTOMA multiforme, DISEASES in older people, BRAIN tumors, NERVOUS system tumors, NERVOUS system cancer
Abstract

Background As yet, no population-based prospective studies have been conducted to investigate the incidence and clinical outcome of glioblastoma (GBM) or the diffusion and impact of the current standard therapeutic approach in newly diagnosed patients younger than aged 70 years. Methods Data on all new cases of primary brain tumors observed from January 1, 2009, to December 31, 2010, in adults residing within the Emilia-Romagna region were recorded in a prospective registry in the Project of Emilia Romagna on Neuro-Oncology (PERNO). Based on the data from this registry, a prospective evaluation was made of the treatment efficacy and outcome in GBM patients. Results Two hundred sixty-seven GBM patients (median age, 64 y; range, 29–84 y) were enrolled. The median overall survival (OS) was 10.7 months (95% CI, 9.2–12.4). The 139 patients ≤aged 70 years who were given standard temozolomide treatment concomitant with and adjuvant to radiotherapy had a median OS of 16.4 months (95% CI, 14.0–18.5). With multivariate analysis, OS correlated significantly with KPS (HR = 0.458; 95% CI, 0.248–0.847; P = .0127), MGMT methylation status (HR = 0.612; 95% CI, 0.388–0.966; P = .0350), and treatment received in a high versus low-volume center (HR = 0.56; 95% CI, 0.328–0.986; P = .0446). Conclusions The median OS following standard temozolomide treatment concurrent with and adjuvant to radiotherapy given to (72.8% of) patients aged ≤70 years is consistent with findings reported from randomized phase III trials. The volume and expertise of the treatment center should be further investigated as a prognostic factor. [ABSTRACT FROM PUBLISHER]

Published
2014

15. Combined Conn's Syndrome and Subclinical Hypercortisolism From an Adrenal Adenoma Associated With Homolateral Renal Carcinoma.

Author

Rossi, Ermanno, Foroni, Moira, Regolisti, Giuseppe, Perazzoli, Franco, Negro, Aurelio, Santi, Rosaria, Grasselli, Chiara, Galli, Paola, and Gardini, Giorgio

Subjects
HYPERTENSION, HYPOKALEMIA, ADRENOCORTICOTROPIC hormone, CARDIOVASCULAR agents, RENAL cancer, CLINICAL pathology, QUALITATIVE research
Abstract

The article presents a case study of a 62-year-old man who was diagnosed with hypertension and hypokalemia. He had been treated with various drugs such as spironolactone, amlodipine and ramipril. Laboratory diagnosis revealed a combination of primary aldosteronism (PA) and adrenocorticotropic hormone (ACTH)-independent hypercortisolism. The prevalence of subclinic hypercortisolism in patients with PA is claimed underestimated.

Published
2008
Full Text
View/download PDF

17. In Reply.

Author

Piana, Simonetta, Frasoldati, Andrea, Gardini, Giorgio, Tallini, Giovanni, and Rosai, Juan

Published
2011
Full Text
View/download PDF

18. Large Cell Neuroendocrine Carcinoma of the Ampulla of Vater.

Author

Cavazza, Alberto, Gallo, Marco, Valcavi, Roberto, De Marco, Loredana, and Gardini, Giorgio

Subjects
*AMPULLA of Vater, *PANCREATIC duct, *CANCER, *CELLULAR pathology, *DIAGNOSIS, *DISEASES
Abstract

We report a large cell neuroendocrine carcinoma arising in the ampulla of Vater. The patient, a 74-year-old woman, presented with a 3-cm ulcerated mass located in the ampullary region. She died of disease 8 months after surgery. Microscopically, the tumor was extensively necrotic. It was composed of islands and trabeculae irregularly infiltrating the muscular wall of the duodenum. Neoplastic cells were large and had a high mitotic index. Immunohistochemically, they expressed cytokeratin, chromogranin, synaptophysin, and neuron-specific enolase. Large cell neuroen-docrine carcinoma is very rare in the ampulla of Vater, and it shares with its more common pulmonary counterpart same morphology and probably the same poor prognosis. [ABSTRACT FROM AUTHOR]

Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results